Emerald Mutual Fund Advisers Trust Insmed Inc Transaction History

Emerald Mutual Fund Advisers Trust

$1.23 Billion
Q1 2025

A detailed history of Emerald Mutual Fund Advisers Trust transactions in Insmed Inc stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 353,831 shares of INSM stock, worth $25.5 Million. This represents 2.19% of its overall portfolio holdings.

Number of Shares

353,831

Previous 400,624 11.68%

Holding current value

$25.5 Million

Previous $27.7 Million 2.41%

% of portfolio

2.19%

Previous 1.9%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	SELL	$65.25 - $83.83 $3.05 Million - $3.92 Million	-46,793 Reduced 11.68%	353,831 $27 Million
Q4 2024 Feb 14, 2025	SELL	$66.29 - $76.63 $5.77 Million - $6.67 Million	-87,040 Reduced 17.85%	400,624 $27.7 Million
Q3 2024 Oct 29, 2024	SELL	$62.0 - $79.01 $383,470 - $488,676	-6,185 Reduced 1.25%	487,664 $35.6 Million
Q2 2024 Aug 06, 2024	BUY	$22.0 - $69.71 $200,970 - $636,800	9,135 Added 1.88%	493,849 $33.1 Million
Q1 2024 May 08, 2024	SELL	$25.72 - $29.94 $6.78 Million - $7.89 Million	-263,630 Reduced 35.23%	484,714 $13.2 Million
Q4 2023 Feb 05, 2024	BUY	$23.42 - $31.74 $84,569 - $114,613	3,611 Added 0.48%	748,344 $23.2 Million
Q3 2023 Oct 26, 2023	SELL	$19.86 - $26.93 $1.8 Million - $2.44 Million	-90,563 Reduced 10.84%	744,733 $18.8 Million
Q2 2023 Aug 10, 2023	SELL	$16.44 - $21.1 $5,392 - $6,920	-328 Reduced 0.04%	835,296 $17.6 Million
Q1 2023 May 04, 2023	BUY	$16.26 - $21.73 $1.44 Million - $1.92 Million	88,478 Added 11.84%	835,624 $14.2 Million
Q4 2022 Feb 03, 2023	BUY	$16.98 - $23.15 $12.7 Million - $17.3 Million	747,146 New	747,146 $14.9 Million
Q1 2020 Apr 30, 2020	SELL	$13.63 - $33.98 $8.41 Million - $21 Million	-617,373 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$16.12 - $24.98 $4.75 Million - $7.36 Million	-294,563 Reduced 32.3%	617,373 $14.7 Million
Q3 2019 Oct 31, 2019	BUY	$15.49 - $25.78 $1.08 Million - $1.8 Million	69,690 Added 8.27%	911,936 $16.1 Million
Q2 2019 Jul 31, 2019	BUY	$23.0 - $32.19 $25,921 - $36,278	1,127 Added 0.13%	842,246 $21.6 Million
Q1 2019 May 01, 2019	BUY	$13.91 - $31.15 $4.57 Million - $10.2 Million	328,472 Added 64.07%	841,119 $24.5 Million
Q4 2018 Jan 31, 2019	SELL	$11.6 - $18.7 $3.87 Million - $6.23 Million	-333,211 Reduced 39.39%	512,647 $6.73 Million
Q3 2018 Oct 31, 2018	BUY	$18.95 - $28.08 $4.09 Million - $6.06 Million	215,743 Added 34.24%	845,858 $17.1 Million
Q2 2018 Jul 31, 2018	BUY	$20.0 - $29.72 $26,720 - $39,705	1,336 Added 0.21%	630,115 $14.9 Million
Q1 2018 Apr 26, 2018	SELL	$21.69 - $32.99 $1.49 Million - $2.26 Million	-68,553 Reduced 9.83%	628,779 $14.2 Million
Q4 2017 Feb 06, 2018	BUY	$26.43 - $31.78 $104,927 - $126,166	3,970 Added 0.57%	697,332 $21.7 Million
Q3 2017 Oct 30, 2017	BUY	$11.61 - $31.21 $8.05 Million - $21.6 Million	693,362	693,362 $21.6 Million

Others Institutions Holding INSM

# of Institutions

506

Shares Held

189M

Call Options Held

3.21M

Put Options Held

2.72M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $9.75B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.

Account

Emerald Mutual Fund Advisers Trust Insmed Inc Transaction History